news 2021

« BACK

Pharmacology



Results 1 - 20 of 41.
1 2 3 Next »


Computer Science - Pharmacology - 20.09.2021
Augmented reality helps tackle fear of spiders
Augmented reality helps tackle fear of spiders
Researchers from the University of Basel have developed an augmented reality app for smartphones in order to help people reduce their fear of spiders. The app has already shown itself to be effective in a clinical trial, with subjects experiencing less fear of real spiders after completing just a few training units with the app at home.

Health - Pharmacology - 16.09.2021
Improving leukemia therapy with targeted treatment approaches
In chronic leukemias, blocking the overactive kinase JAK2 by a targeted therapy approach is only mitigating the patients' symptoms, but cannot truly change the course of the disease. A study by the University of Basel has shown that it may be possible to improve the therapeutic effects by additionally inhibiting a specific signaling pathway.

Pharmacology - Chemistry - 13.09.2021
New immunotherapy method turns activated specifically in tumor
New immunotherapy method turns activated specifically in tumor
Scientists have developed a chemical method for targeting the effects of cancer-fighting immunotherapy drugs only to the tumor tissue, making the drugs less toxic to the rest of the human body. Immunotherapy drugs are promising new weapons in the fight against cancer, but they are so strong that they can be toxic to the rest of the human body.

Health - Pharmacology - 01.09.2021
Nasal cartilage relieves osteoarthritis in the knee
Nasal cartilage relieves osteoarthritis in the knee
Cartilage cells from the nasal septum can not only help repair cartilage injuries in the knee - according to researchers from the University of Basel and the University Hospital Basel, they can also withstand the chronic inflammatory tissue environment in osteoarthritis and even counteract the inflammation.

Health - Pharmacology - 16.08.2021
Lung cancer: Hope for increasing immunotherapy efficacy
Lung cancer: Hope for increasing immunotherapy efficacy
A "paradox and setback" forced scientists to dig deeper when seeking a means to boost the power of immunotherapy in lung cancer. Understanding the problem - and finding the solution - has led to a promising potential therapy for some patients. Lung cancer is the leading cause of cancer-related death.

Pharmacology - Health - 12.08.2021
New database could accelerate drug repurposing for various diseases
New database could accelerate drug repurposing for various diseases
NICEdrug.ch, a new database developed by a group of researchers from EPFL, may help scientists assess potential drugs more quickly, including how they are metabolized by the body and their potential side effects. Researchers from EPFL have created a new open-access database of information on drug candidates and how they are metabolized by the body, which could help speed up the repurposing of old drugs as new treatments.

Health - Pharmacology - 03.08.2021
Breath test to determine correct treatment for epilepsy
Breath test to determine correct treatment for epilepsy
Breath instead of blood: researchers from the University of Basel have developed a new test method to measure treatment success in epilepsy patients. They hope that this will enable doctors to react more precisely when treating the disease. Epilepsy affects some 50 million people worldwide and pharmaceutical treatment of the disease is a tightrope walk, as the dose must be tailored precisely to the individual patient: "Slightly too little and it isn't effective.

Life Sciences - Pharmacology - 21.07.2021
Toxicity testing on the placenta and embryo
Toxicity testing on the placenta and embryo
Researchers at ETH Zurich have developed a cell culture test to detect substances that are directly or indirectly harmful to embryos. Based on an existing test used for developing new drugs and chemicals, the augmented version is designed to help reduce the number of animal experiments. Drugs must be safe not just for the patients; in the case of pregnant patients, drugs must also be safe for the unborn children still in the womb.

Health - Pharmacology - 15.07.2021
Why do scientific discovery take so long to reach the general public?
Why do scientific discovery take so long to reach the general public?
SUMMER SERIES: HOW SCIENCE WORKS For scientists, the path from bright idea to finished product is a long one. Prototypes must go through an extensive testing and approval process before they are ready for the market. Let's have a look. The results of scientific research can often bring considerable societal and economic benefits.

Health - Pharmacology - 15.07.2021
Why do scientific discoveries take long to reach the general public?
Why do scientific discoveries take long to reach the general public?
SUMMER SERIES: HOW SCIENCE WORKS For scientists, the path from bright idea to finished product is a long one. Prototypes must go through an extensive testing and approval process before they are ready for the market. Let's have a look. The results of scientific research can often bring considerable societal and economic benefits.

Pharmacology - Chemistry - 07.07.2021
Harnessing AI to discover new drugs inspired by nature
Artificial intelligence (AI) is able to recognise the biological activity of natural products in a targeted manner, as researchers at ETH Zurich have demonstrated. Moreover, AI helps to find molecules that have the same effect as a natural substance but are easier to manufacture. This opens up huge possibilities for drug discovery, which also have potential to rewrite the rulebook for pharmaceutical research.

Health - Pharmacology - 06.07.2021
Covid long affects four out of ten people
Covid long affects four out of ten people
More than seven months after contracting the virus, nearly 40% of symptomatic people who test positive for SARS-CoV-2 still have symptoms, reveals a study by the UNIGE and the HUG. A study by Geneva University Hospitals (HUG) and the University of Geneva on the long-term follow-up of symptomatic individuals who tested positive for SARS-CoV-2 has revealed that 39% of patients report residual symptoms seven to nine months after contracting the virus.

Health - Pharmacology - 02.07.2021
Cancer: immunotherapies without side effects?
Cancer: immunotherapies without side effects?
By identifying the mechanism of toxicity induced by immunotherapies, scientists from the University of Geneva and from the Harvard Medical School are paving the way for cancer treatments with fewer side effects. In recent years, immunotherapy has revolutionised the field of cancer treatment. However, inflammatory reactions in healthy tissues frequently trigger side effects that can be serious and lead to the permanent discontinuation of treatment.

Health - Pharmacology - 16.06.2021
Immune defense: How immune cells are activated
Immune defense: How immune cells are activated
Immune cells protect our body against invading pathogens. The chemokine receptor CCR5 on the surface of T cells plays an important role in this process. However, CCR5 also is used by the HI-Virus as entrance gate into T cells. A research consortium led by the University of Basel has now deciphered the mechanism of CCR5 receptor activation.

Pharmacology - Health - 02.06.2021
Replicating patients' tumours to test different treatments
Replicating patients’ tumours to test different treatments
UNIGE Researchers have developed in vitro tumour models that incorporate components of the tumour and elements of the patient's immune system to test the effectiveness of treatments. Every tumour is different, every patient is different. So how do we know which treatment will work best for the patient and eradicate the cancer?

Pharmacology - Life Sciences - 01.06.2021
Protecting the IQ of people at risk for psychosis
Protecting the IQ of people at risk for psychosis
A team from the University of Geneva has found that a class of drugs can protect the development of intellectual abilities in people at risk of psychosis, if prescribed before adolescence. One person in 2000 suffers from a microdeletion of chromosome 22 that can lead to the development of psychotic disorders, such as schizophrenia, in adolescence.

Health - Pharmacology - 31.05.2021
Moving one step closer to personalized anesthesia
Moving one step closer to personalized anesthesia
Researchers have developed a device that can continuously measure the blood concentration of propofol - one of the main compounds used in anesthetics - in patients as they're being operated on. That will help anesthesiologists deliver more personalized doses. Anesthesia may be an exact science, but it's not yet fully personalized.

Health - Pharmacology - 27.05.2021
Cell encapsulation could enhance antiviral vaccines
Cell encapsulation could enhance antiviral vaccines
A team from the UNIGE and the HUG has developed a new and effective anti-viral vaccination technique based on the cell encapsulation. Immunotherapy techniques developed in oncology to combat cancerous cells have great potential for fighting viruses. A research team from the University Hospitals of Geneva (HUG) and the University of Geneva , in Switzerland, in collaboration with MaxiVAX, a spinoff of both institutions, developed an innovative technology called "cell encapsulation".

Health - Pharmacology - 18.05.2021
New Technology Makes Tumor Eliminate Itself
New Technology Makes Tumor Eliminate Itself
A new technology enables the body to produce therapeutic agents on demand at the exact location where they are needed. The innovation could reduce the side effects of cancer therapy and may hold the solution to better delivery of Covid-related therapies directly to the lungs. Scientists at the University of Zurich have modified a common respiratory virus, called adenovirus, to act like a Trojan horse to deliver genes for cancer therapeutics directly into tumor cells.

Health - Pharmacology - 06.05.2021
Biomarker Detects Severe COVID-19 Early On
Severe cases of COVID-19 can now be detected at an early stage. Researchers at the University of Zurich have identified the first biomarker that can reliably predict which patients will develop severe symptoms. This can help to improve the treatment of severe cases of COVID-19. Most people who are infected with SARS-CoV-2 develop no or only mild symptoms.
1 2 3 Next »